Effect of Cocoa Supplementation Peripheral and Autonomic Diabetic Neuropathy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carlos Cuéllar-Ramos, PhD
Anahuac University
Study Director - Gabriela Gutiérrez-Salmeán, PhD
Anahuac University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universidad Anáhuac México Norte
Huixquilucan, State of Mexico, Mexico
- Centro de Especialidades del Riñón
Naucalpan, State of Mexico, Mexico
- Clínica de Medicina Familiar "nueva Oxtotitlán" Issste
Toluca, State of Mexico, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jun 2021
- Primary completion
- 30 Jun 2024
- Completion
- 3 Sept 2024
- Last update posted
- 1 May 2025
- Registered enrollment
- 39
- Registry id
- NCT05247034
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.